Sturniolo GC - Search Results

1

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.

Prantera C, Lochs H, Campieri M, Scribano ML, Sturniolo GC, Castiglione F, Cottone M. Prantera C, et al. Among authors: sturniolo gc. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1117-25. doi: 10.1111/j.1365-2036.2006.02879.x. Aliment Pharmacol Ther. 2006. PMID: 16611272 Clinical Trial.

2

Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group.

d'Albasio G, Paoluzi P, Campieri M, Bianchi Porro G, Pera A, Prantera C, Sturniolo GC, Miglioli M. d'Albasio G, et al. Among authors: sturniolo gc. Am J Gastroenterol. 1998 May;93(5):799-803. doi: 10.1111/j.1572-0241.1998.228_a.x. Am J Gastroenterol. 1998. PMID: 9625131 Clinical Trial.

3

Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto.

Frieri G, Pimpo MT, Andreoli A, Annese V, Comberlato M, Corrao G, Palumbo G, Sturniolo GC, Tonelli F, Caprilli R. Frieri G, et al. Among authors: sturniolo gc. Aliment Pharmacol Ther. 1999 May;13(5):577-82. doi: 10.1046/j.1365-2036.1999.00501.x. Aliment Pharmacol Ther. 1999. PMID: 10233180

4

Hepatitis B and C virus infection in Crohn's disease.

Biancone L, Pavia M, Del Vecchio Blanco G, D'Incà R, Castiglione F, De Nigris F, Doldo P, Cosco F, Vavassori P, Bresci GP, Arrigoni A, Cadau G, Monteleone I, Rispo A, Fries W, Mallardi B, Sturniolo GC, Pallone F; Italian Group for the Study of the Colon and Rectum (GISC). Biancone L, et al. Among authors: sturniolo gc. Inflamm Bowel Dis. 2001 Nov;7(4):287-94. doi: 10.1097/00054725-200111000-00002. Inflamm Bowel Dis. 2001. PMID: 11720317

5

Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.

Paoluzi P, D'Albasio G, Pera A, Bianchi Porro G, Paoluzi OA, Pica R, Cottone M, Miglioli M, Prantera C, Sturniolo G, Ardizzone S. Paoluzi P, et al. Dig Liver Dis. 2002 Nov;34(11):787-93. doi: 10.1016/s1590-8658(02)80072-x. Dig Liver Dis. 2002. PMID: 12546514 Clinical Trial.

6

Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.

Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, Papi C, Viscido A, Cammà C, Corrao G, Latella G. Caprilli R, et al. Aliment Pharmacol Ther. 2003 Feb 15;17(4):517-23. doi: 10.1046/j.1365-2036.2003.01462.x. Aliment Pharmacol Ther. 2003. PMID: 12622760 Clinical Trial.

7

Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients.

Di Sabatino A, Ciccocioppo R, Benazzato L, Sturniolo GC, Corazza GR. Di Sabatino A, et al. Among authors: sturniolo gc. Aliment Pharmacol Ther. 2004 May 1;19(9):1019-24. doi: 10.1111/j.1365-2036.2004.01927.x. Aliment Pharmacol Ther. 2004. PMID: 15113369

8

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Caprilli R, et al. Among authors: sturniolo gc. Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.

9

Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study.

Riegler G, Caserta L, Castiglione F, Esposito I, Valpiani D, Annese V, Zoli G, Gionchetti P, Viscido A, Sturniolo GC, Rispo A, De Filippo FR, de Leone A, Carratu R; IG-IBD Group. Riegler G, et al. Among authors: sturniolo gc. Dig Liver Dis. 2006 Jan;38(1):18-23. doi: 10.1016/j.dld.2005.07.006. Epub 2005 Sep 19. Dig Liver Dis. 2006. PMID: 16169781

10

Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.

D'Incà R, Annese V, di Leo V, Latiano A, Quaino V, Abazia C, Vettorato MG, Sturniolo GC. D'Incà R, et al. Among authors: sturniolo gc. Aliment Pharmacol Ther. 2006 May 15;23(10):1455-61. doi: 10.1111/j.1365-2036.2006.02916.x. Aliment Pharmacol Ther. 2006. PMID: 16669960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters